膵臓がんはついに敗れるのか？
膵臓がんは最も致命的ながんのひとつで、発見が遅れることが多く、治療も極めて困難である。しかし、近年の研究により、遺伝子変異の特定、早期発見法の開発、新たな標的治療薬の登場など、画期的な進展が見られている。本稿は、この難治がんを克服するための最前線の取り組みを解説する。
関連記事
Eric Topol highlights remarkable progress in cancer immunotherapy, noting that vaccines are now achieving cures or remissions in some of the most refractory cancers, including pancreatic, melanoma, glioblastoma, renal, and triple-negative breast cancer.
Colorectal cancer rates are increasing among younger adults, but the article urges caution in interpreting the trend, noting that absolute risk remains low and that the rise is partly due to improved detection and screening practices.
A new episode of Hard Drugs features Katharine Collins, who co-invented the R21 malaria vaccine during her PhD at Oxford's Jenner Institute. By modifying the expired patent of the first malaria vaccine (RTS,S), she created a cheaper, more scalable vaccine with a higher proportion of malaria antigen, making it more accessible for children worldwide.